Healthcare systems worldwide are under immense pressure to deliver cost-effective, value-based care to an aging population, often beset with complex lifestyle-related chronic illnesses.
Sustainability requires a shift in focus from episodic to continuous care, where patients monitor their health and co-manage their treatment remotely.
We help healthcare companies develop digital health solutions that leverage recent advancements in connectivity and data science for competitive advantage.
Data that delivers
Our experience in connectivity, big data, machine learning and digital services means we are ideally placed to help our clients seize the huge and disruptive opportunities these create to improve patient outcomes.
Smart connected devices
We have a proven track record developing both consumer and medical connected devices and establishing the infrastructure that allows our clients to harness their data.
Having developed the world's first single-chip Bluetooth solution – now used in over 70% of all smartphones – our more recent breakthroughs include the first 24/7 wrist-worn activity monitor, the first wireless pacemaker, the first wireless patient monitor and the first connected inhaler.
Digital health strategy
We provide strategic advice on long-term strategic roadmaps, business system integration, digital transformation and go-to-market strategies.
We can assist across the entire digital health journey including: creating compelling strategies and strong stories for investors; shaping the teams and partnerships needed to support digital services; rapid prototyping of service offerings; and roadmap innovation and development.
Interested in joining us?
Tech, tools & facilities
Anechoic test chamber
Our custom anechoic radio and antenna test chamber is a highly sophisticated 5m cube. Inside, we carry out automated three-dimensional measurement and visualization of wireless device behavior and test body-worn technology using body phantoms or real live test subjects. This helps us to understand and optimize real-word RF performance of products such as smart implants (including implanted telemetry), connected drug delivery devices and wearables.
Life science labs
Our suite of restricted Class II laboratories is specifically designed for handling and experimentation of pharmaceuticals, licensed substances, biological hazards and human samples in a controlled and regulated environment. Our instrumentation rooms are equipped with metrology, microscopy and product test equipment for rigorous verification and quality assurance of prototypes and products.
Our electronic and mechanical prototyping workshops allow us to produce technically credible prototypes that bring ideas to life and offer a powerful demonstration of their value. All while maintaining extremely high standards of quality that conform to ISO 9001, ISO 13485 and ISO 14001 regulations. Using the latest CNC and milling machines, lathes, welding gear and wire harness and cable assembly tools, we are able to produce parts very quickly and assemble full-scale working prototypes for testing and consumer trials.
Surgical innovation suite
Equipped to simulate clinical, home and office environments, this facility allows us to test concepts, evaluate prototypes and analyse workflows in a safe and confidential setting. It’s an invaluable tool for understanding and communicating the contextual implications of design decisions, while the ability to conduct quick-turnaround usability evaluations means we can efficiently progress design and development.
The Digital Greenhouse is our purpose-built AI research facility, specifically designed to discover, develop, and test machine learning approaches in a fast, secure environment. The facility features an NVIDIA DGX-1 Deep Learning Supercomputer, a bank of machine learning computers, petabyte local storage, and many teraflops of dedicated compute power.
We can help you
achieve the seemingly impossible
From Harvard start-up to fitness tech powerhouse: how WHOOP developed its first wearable
Before athletes even thought about how technology could improve their performance, Harvard students Will Ahmed and John Capodilupo struck on an idea to revolutionize physiological monitoring for both professional and college athletes. Today their creation – WHOOP – is a global training phenomenon relied on by NFL footballers, Olympic athletes, PGA Tour golfers and an exploding number of consumers and weekend warriors.
This is the story of digital services innovation that is disrupting traditional markets while helping companies make their product offerings more sustainable, cost efficient and safe. At the heart of the story is a low-cost asset-monitoring sensing tag that is small, light and powerful enough be stuck just about anywhere. This core technology concept, now called DriveTag, is helping our client Sycada with its mission to prove that sustainability can go hand in hand with healthy ROI.
Universal Autoinjector Platform
A visionary medical device, beautiful and effortless to use
The Saranas Early Bird Bleed Monitoring System
A world-first for endovascular bleed detection
News & insights
Cambridge Consultants announces its collaboration with MedTech Innovator, a world-leading non-profit start-up accelerator
Cambridge Consultants part of Capgemini, today announced its collaboration with MedTech Innovator Asia Pacific, the world’s leading non-profit accelerator of medical devices
Device for treating gait deficit caused by multiple sclerosis receives FDA marketing authorization
Helius Medical Technologies’ groundbreaking PoNS device for short-term treatment of gait deficit due to multiple sclerosis has received marketing authorization from the U.S. Food and Drug Administration (FDA).
The what, why and how of connected medical implant development for personalized delivery of medicine
The medical implant industry is set to grow from $5bn in 2017 to $16.3bn by 2022. But there are tensions to understand and hurdles to overcome for innovators intent on taking advantage.
- Connectivity & IoT
- Digital health
- Product realisation
Unconventional outlook: medtech innovation in 2023
2022 was a rollercoaster year for medtech innovation, with a dramatic slow-down of venture funding, multi-national corporations (MNCs) hitting inflationary, recessionary, and geo-political headwinds, new emerging technologies, and the sprinkling of game-changing M&A. Rahul Sathe shares his predictions on medtech’s innovation outlook for 2023.
- Digital health
- Digital service innovation
- Innovation management
- Strategic advice
Hamlyn Symposium on Medical Robotics 2023
The Hamlyn Robotics Symposium provides a forum for international surgeons and engineers to network and share the latest developments on medical robotics, attracting attendees from a wide range of disciplines associated with medical robotics and surgery. This year’s event will focus on ‘Immersive Tech: The Future of Medicine’.
North American Neuromodulation Society (NANS) Forum 2023
NANS 2023 Annual Meeting will showcase the latest advances in the field through cutting edge plenary sessions, concurrent sessions, and oral abstract presentations in neuromodulation.
American Drug Delivery & Formulation Summit 2022
Join us live in San Diego, California on September 26-27 2022 for 2 days of innovative presentation, intelligent debate and targeted networking with business leaders in the pharmaceutical, biologics and device developments.
IPAC-RS Webinar: What is a digital biomarker and why is it important?
The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is launching a Roundtable webinar series on digital devices for 2021.